|
|
Blood, 1 August 2005, Vol. 106, No. 3, pp. 787-794.
Prepublished online as a Blood First Edition Paper on April 12, 2005; DOI 10.1182/blood-2004-12-4643.
 Previous Article | Table of Contents | Next Article 
REVIEW IN TRANSLATIONAL HEMATOLOGY
RNA interference in biology and disease
Carol A. Sledz, and
Bryan R. G. Williams
From the Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH.
Abstract
RNA interference (RNAi) is a conserved biologic response to double-stranded RNA that results in the sequence-specific silencing of target gene expression. Over the past 5 years, an intensive research effort has facilitated the rapid movement of RNAi from a relatively obscure biologic phenomenon to a valuable tool used to silence target gene expression and perform large-scale functional genomic screens. In fact, recent studies reported in this journal and others have demonstrated success using RNAi to address the role of oncogene expression in leukemia cell lines and to validate the therapeutic potential of RNAi for treating these blood disorders. In order to advance these applications and gain an appreciation for the future of RNAi both in basic research and in the treatment of diseases caused by aberrant gene expression, it is important to have an understanding of the process of RNAi and its limitations.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. Profita, A. Sala, A. Bonanno, L. Siena, M. Ferraro, R. Di Giorgi, A. M. Montalbano, G. D. Albano, R. Gagliardo, and M. Gjomarkaj
Cysteinyl Leukotriene-1 Receptor Activation in a Human Bronchial Epithelial Cell Line Leads to Signal Transducer and Activator of Transcription 1-Mediated Eosinophil Adhesion
J. Pharmacol. Exp. Ther.,
June 1, 2008;
325(3):
1024 - 1030.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-P. Jin, Y. Korin, X. Zhang, P. T. Jindra, E. Rozengurt, and E. F. Reed
RNA Interference Elucidates the Role of Focal Adhesion Kinase in HLA Class I-Mediated Focal Adhesion Complex Formation and Proliferation in Human Endothelial Cells
J. Immunol.,
June 15, 2007;
178(12):
7911 - 7922.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Diakos, G. Krapf, C. Gerner, A. Inthal, C. Lemberger, J. Ban, A. M. Dohnal, and E. R. Panzer-Gruemayer
RNAi-mediated silencing of TEL/AML1 reveals a heat-shock protein- and survivin-dependent mechanism for survival
Blood,
March 15, 2007;
109(6):
2607 - 2610.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Deschamps and F. G. Spinale
Pathways of matrix metalloproteinase induction in heart failure: Bioactive molecules and transcriptional regulation
Cardiovasc Res,
February 15, 2006;
69(3):
666 - 676.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Koss, G. R. Pfeiffer II, Y. Wang, S. T. Thomas, M. Yerukhimovich, W. A. Gaarde, C. M. Doerschuk, and Q. Wang
Ezrin/Radixin/Moesin Proteins Are Phosphorylated by TNF-{alpha} and Modulate Permeability Increases in Human Pulmonary Microvascular Endothelial Cells
J. Immunol.,
January 15, 2006;
176(2):
1218 - 1227.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Schiffer
Clinical Issues in the Management of Patients with Myelodysplasia
Hematology,
January 1, 2006;
2006(1):
205 - 210.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
